Humanetics Corporation: Clinical Trials

8 trials sponsored by Humanetics Corporation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 unknown. 5 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Unknown 1
Phase 14Completed 4

Follow Humanetics Corporation: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 BIO 300 Oral Suspension
BIO 300 Oral Suspension - Healthy Volunteer Study
Phase 1CompletedHumanetics Corporation562024-12-232025-10-30
BIO 300 Oral Powder Safety and Pharmacokinetics
BIO 300 Oral Powder - Acute Radiation Syndrome
Phase 1CompletedHumanetics Corporation342020-12-082024-05-03
BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients
BIO 300 Oral Suspension, Placebo - COVID-19, Long COVID
Phase 2UnknownHumanetics Corporation502020-11-112024-10-01
BIO 300 Non-Small Cell Lung Cancer Study
BIO 300 Oral Suspension, Paclitaxel, Carboplatin - Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2CompletedHumanetics Corporation212015-11-012024-01-25
7-Keto DHEA for the Treatment of PTSD
7-Keto Dehydroepiandrosterone, Placebo - PTSD
Phase 2CompletedHumanetics Corporation712013-02-012015-10-29
Safety and Pharmacokinetic Study of BIO 300 Capsules
BIO 300 Capsules - Acute Radiation Syndrome
Phase 1CompletedHumanetics Corporation242007-06-012015-03-17
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Drug: NIC5-15, Placebo - Alzheimer's Disease, Dementia
Phase 2CompletedHumanetics Corporation302007-04-012016-10-17
Development of NIC5-15 in the Treatment of Alzheimer's Disease
NIC5-15, Placebo - Alzheimer Disease, Dementia
Phase 2CompletedVA Office of Research and Development152007-01-012017-01-09

Conditions studied

Acute Radiation Syndrome (3)  ·  Alzheimer Disease (2)  ·  Dementia (2)  ·  Diabetes Mellitus (2)  ·  Brain Diseases (1)  ·  COVID-19 (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Central Nervous System Diseases (1)  ·  Delirium (1)  ·  Disease (1)  ·  Lung Neoplasms (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Post-Acute COVID-19 Syndrome (1)

Interventions

Genistein (2)  ·  pinitol (2)  ·  7-oxodehydroepiandrosterone (1)  ·  Carboplatin (1)  ·  Paclitaxel (1)  ·  Radiotherapy (1)

Countries

United States (7)

Top investigators

Hillel Grossman, MD (2)  ·  Alina Gonzalez-Mayo, MD (1)  ·  John L Zenk, MD (1)  ·  Michael D Kaytor, Ph.D. (1)  ·  Michael D. Kaytor, PhD (1)

Results publications

PMID 28489488, PMID 36301689

NIH funding

R21AT003302 (2), 272201800011C-P00005-9999-1 (1)